Cure My Disease

Don't miss your cure!

 Log in / Sign up

New breathing monitor put to the test in small study

NCT ID NCT06521385

Knowledge-focused Sponsor: Makani Science Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new, non-invasive device that monitors breathing rate by comparing it to the current standard method (capnography) in 32 healthy adults. The goal was to see if the new device gives accurate readings. The study did not treat any disease, but rather aimed to see if the new technology works well enough for future use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

32 people

The number who actually took part.

Started

May 2024

Finished

Jul 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

22 to 99 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Between age of 22-99 * BMI between 15 and 40 kg/m\^2 Exclusion Criteria: * Medical history of serious symptomatic, cardiac, or pulmonary disease. * History of serious skin irritation (severe rash or blisters) caused by medical adhesives (tape). * Cannot lay still for one (1) hour. * Cannot give written informed consent. * Unable to follow instructions.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Respiratory monitoring are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Respiratory monitoring

Contacts and locations

Locations

  • Illumination Foundation

    Fullerton, California, 92833, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.